Remove Hospitals Remove Immunity Remove Labelling
article thumbnail

Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial

pharmaphorum

The phase 3 open-label trial will test the cocktail in patients hospitalised with COVID-19 and will compare the effects of adding the antibody cocktail REGN-COV2 to the usual standard-of-care versus standard-of-care on its own. The post Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial appeared first on.

article thumbnail

How advanced technology can streamline the COVID-19 vaccine rollout

pharmaphorum

The integration of real-time track and trace technology, handheld mobile smart devices and advanced analytics solutions into the COVID-19 vaccine rollout is our best shot to enhance the global vaccination effort and combat new variants with herd immunity. Critical supply chain visibility.

Vaccines 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

Dr Jacob Thyssen, an expert on AD, and professor at the University of Copenhagen, dermatologist at Bispebjerg Hospital, as well as senior author of lebrikizumab’s ADvocate analyses, spoke to pharmaphorum soon after presenting the findings at The European Academy of Dermatology and Venerology (EADVC) on 8th September.

article thumbnail

Ichnos Glenmark Innovation presents first clinical data from phase 1 study of Trispecific TREAT Antibody, ISB 2001

Express Pharma

Professor of Haematology, University of Melbourne and Director of Haematology, St Vincents Hospital Melbourne. ISB2001 Phase 1 Dose Escalation Study Design The Phase 1, first-in-human, open-label study is evaluating the safety and anti-myeloma activity of ISB2001 in patients with RRMM. The median duration of CRS was 2 days (range: 18).

article thumbnail

FDA Approvals: September 2022 Recap

Digital Pharmacist

Terlivaz is the first and only FDA-approved product indicated to improve kidney function in adults with HRS with a rapid reduction in kidney function, an acute and life-threatening condition requiring hospitalization. Its FDA approval was announced by Mallinckrodt plc.

article thumbnail

The Best Probiotics for Hashimoto’s

The Thyroid Pharmacist

This irritation can interrupt the immune system’s ability to regulate itself, and put the body into a perpetual “attack mode” that is counterproductive to healing. Immune system health and gut health are linked. They can help improve digestion and nutrient extraction from the foods we eat, and can also balance the immune system.

article thumbnail

Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trial

pharmaphorum

But the findings of the latest phase 3 study, EMPACTA, could change that after Roche said it plans to share results with the FDA and other regulators to get its label expanded on the basis of the latest results. The cumulative proportion of patients who progressed to mechanical ventilation or death by day 28 was 12.2% in the placebo arm.